MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific Depreciation & Amortization 2011-2026 | TMO
Annual Depreciation & Amortization Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.05 B | 1.16 B | 1.07 B | 986 M | 831 M | 658 M | 564 M | 2.27 B | 2.03 B | 1.76 B | 1.69 B | 1.68 B | 1 B | 984 M | 864 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.27 B | 564 M | 1.24 B |
Quarterly Depreciation & Amortization Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 227 M | 256 M | 276 M | 291 M | 276 M | 285 M | - | - | 253 M | - | 730 M | - | 250 M | - | 614 M | - | 198 M | - | 467 M | 306 M | 149 M | - | 416 M | 275 M | 133 M | - | 132 M | 130 M | 575 M | - | 1.46 B | 942 M | 465 M | - | 1.28 B | 851 M | 416 M | - | 1.26 B | 836 M | 416 M | - | 1.26 B | 800 M | 366 M | - | 751 M | 500 M | 251 M | - | 729 M | 484 M | 242 M | - | 614 M | 385 M | 184 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.46 B | 130 M | 506 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
47 M | $ 8.96 | 1.01 % | $ 597 M |  USA |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 25.94 | 0.43 % | $ 721 M | USA |
 |
DexCom
DXCM
|
252 M | $ 68.13 | 2.7 % | $ 26.6 B | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 154.1 | 1.4 % | $ 7.64 B | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 17.47 | 0.87 % | $ 931 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 88.35 | 1.34 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | $ 103.93 | 0.08 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 15.57 | 4.11 % | $ 471 M | USA |
 |
IQVIA Holdings
IQV
|
1.14 B | $ 168.8 | 2.43 % | $ 29 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 17.35 | 0.35 % | $ 2.25 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 99.75 | 2.19 % | $ 8.23 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 2.86 | 0.7 % | $ 92.8 K | USA |
 |
Danaher Corporation
DHR
|
750 M | $ 195.49 | 2.14 % | $ 139 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
354 M | $ 122.2 | 2.45 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 199.41 | 0.23 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
321 M | $ 113.82 | 1.78 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.13 | 1.35 % | $ 1.44 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 9.02 | 7.13 % | $ 256 M |  Israel |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.31 | 0.85 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.26 | 1.59 % | $ 2.01 B | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 79.31 | 1.03 % | $ 5.35 B | USA |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.42 | 4.04 % | $ 426 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
1.23 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 454.33 | 0.15 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 219.09 | 1.66 % | $ 25.1 B |  Schweiz |
 |
Celcuity
CELC
|
130 K | $ 114.35 | -0.48 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 17.74 | 1.95 % | $ 397 M | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
16.7 M | $ 200.3 | 1.33 % | $ 19.7 B | USA |
 |
OPKO Health
OPK
|
98.2 M | $ 1.2 | 0.42 % | $ 833 M | USA |